Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
This report contains market size and forecasts of Stem Cells in Global, including the following market information:
- Global Stem Cells Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Stem Cells market was valued at 2832.7 million in 2021 and is projected to reach US$ 5673.4 million by 2028, at a CAGR of 10.4% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stem Cell Storage Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Stem Cells include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Stem Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stem Cells Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Stem Cells Market Segment Percentages, by Type, 2021 (%)
- Stem Cell Storage
- Stem Cell Pharmaceutical and Treatment
Global Stem Cells Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Stem Cells Market Segment Percentages, by Application, 2021 (%)
- Blood Disease
- Cancer
- Autoimmune Disease
- Others
Global Stem Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Stem Cells Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Stem Cells revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Stem Cells revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Osiris Therapeutics
- NuVasive
- Chiesi Pharmaceuticals
- Medi-post
- JCR Pharmaceutical
- MolMed
- Pharmicell
- Anterogen
- Takeda (TiGenix)
- CBR
- ViaCord
- Esperite
- LifeCell
- CCBC
- VCANBIO
- BOYA LIFE
- Beike Biotechnology
- International Medical
- Global Cord Blood Corporation
- Beijing Health-Biotech Group
- ABMD
